On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Rising Medical Costs, but No Solution in Sight
May 28th 2010Nearly everyone agrees that the rising cost of healthcare is unsustainable and that the current efforts at healthcare reform will do little if anything to reduce healthcare expenditures. Although there seems to be no shortage of proposals on what should be done, there is little consensus on whether any of them will succeed.
NO-Naproxen May Protect Against Colorectal Cancer
May 28th 2010A study presented at the AACR 101st Annual Meeting 2010 by researchers from the Fox Chase Cancer Center, Philadelphia, Pennsylvania, provides further evidence that non-steroidal anti-inflammatory drugs (NSAIDs) are promising chemopreventive agents with activity against colorectal cancer.
Endocrine-disrupting Chemicals Have Toxic Role in Development and Health
May 28th 2010Exposure to these chemicals, such as BPA, during organogenesis and throughout life can lead to changes in neuroendocrinology, behavior, metabolism, and obesity, prostate cancer and thyroid and cardiovascular endocrinology.
New Gene Technology Assesses Nine Genes that may Predict Response to Panitumumab
May 28th 2010Although KRAS gene mutation is a well-established biomarker for a lack of response to anti-epidermal growth factor receptor (anti-EGFR) antibodies in colorectal cancer, a study presented at the AACR 101st Annual Meeting 2010 sought to determine whether mutations in 9 genes known to be mutated in colorectal cancer, including AKT1, BRAF, CTNNB1, EGFR, KRAS (exon 3), NRAS, PIK3CA, PTEN, and TP53, could also predict response to Vectibix (panitumumab) in patients with metastatic colorectal cancer.
RANK Ligand and Skeletal-Related Events in Patients with Cancer
May 28th 2010Bone is a common site of metastases for many patients with cancer; 65% to 75% of patients who die from breast or prostate cancer have bone metastases, and 30% to 40% of patients with non–small cell lung cancer develop bone metastasis.
FDA Asks Physicians to Play Big Brother to Big Pharma
Jill Taylor contrasts the role of psychiatrists and primary care physicians in prescribing psychiatric medications, reviews recent regulatory challenges for the pharma industry, and wonders why the APSS refuses to embrace the Internet.
Mind-Body Fitness: Three Options for Patients with Cancer
May 26th 2010Mind-body fitness focuses on the connections between thinking, feeling, and doing. These exercises change energy patterns within the body, facilitating relaxation, reducing fatigue, and improving concentration. Because they also can be modified to suit a person�¢ï¿½ï¿½s needs on any given day, they may be appealing to patients with cancer.